EDC for supplement clinical trials: dietary supplement studies with 21 CFR Part 11–aligned controls and one platform.
21 CFR Part 11 aligned · HIPAA-aligned security · No credit card required
Supplement studies often rise or fall on adherence. A participant may be assigned a capsule, sachet, powder, liquid, gummy, or other dosage form, and the protocol may require daily intake, split dosing, intake with food, avoidance of certain products, or return of unused product at each visit. If that information is collected inconsistently, the final analysis can be difficult to interpret even when the study is otherwise well designed. Capture gives teams a structured way to document supplement dosing and adherence inside the EDC. Forms can capture product assignment, dose level, dosing schedule, dispensed quantity, returned quantity, missed doses, and reasons for interruption. ePRO diaries can be used when the protocol needs participant-entered intake logs between visits, while coordinator-entered CRFs can document accountability and reconciliation during site visits. This helps sponsors and investigators distinguish between lack of effect and lack of exposure. If a participant has poor adherence, stops the supplement, changes timing, or uses a prohibited product, the study team can capture that context in the same participant record as outcomes and safety data. The result is a cleaner dataset for per-protocol analysis, safety review, and publication.
Dietary supplement trials still need disciplined safety capture. Even when the intervention is lower risk than an investigational drug, participants may report gastrointestinal symptoms, sleep changes, headaches, allergic reactions, changes in appetite, interactions with concomitant products, or other events that need to be documented and reviewed. Teams also need to capture whether the event was possibly related to the supplement, the dosing schedule, the participant's diet, or another factor. Capture supports supplement-specific safety forms without requiring a heavy enterprise safety system. Study teams can configure adverse event forms with onset, severity, seriousness, relationship, action taken, outcome, and follow-up status. Related forms can capture concomitant medications, other supplements, rescue products, diet restrictions, or protocol deviations that may affect interpretation. Because these records are part of the same platform as consent, CRFs, and ePRO, the safety review is easier to follow. Investigators and monitors can see the participant's adherence, symptom reports, product exposure, and adverse events together. That matters for small studies where every participant can materially affect the safety and efficacy readout.
Many supplement trials are run by small sponsor teams, academic collaborators, clinics, or contract research partners with limited time for software implementation. The EDC needs to be structured enough for auditability but simple enough for coordinators and investigators to use without a long build cycle. A system designed for large pharmaceutical programs can introduce cost and administrative work that is disproportionate to the study scope. Capture is built around configurable study forms, eConsent, ePRO, role-based access, and exports in one platform. A supplement team can start with the required visits and forms, add adherence diaries only when they are needed, and keep the operational workflow understandable for sites. Monitors can review data and queries without moving between separate consent, diary, and CRF tools. For teams preparing a manuscript, substantiation package, or regulatory-facing report, that simplicity is paired with traceability. Audit trails show changes to participant records. Role permissions define who can enter, review, sign, or export data. Structured exports support analysis without relying on manual consolidation from paper diaries and spreadsheets.
Overview
Supplement clinical trials evaluate the safety and efficacy of dietary supplements in human subjects. Your EDC must support consent, CRFs, compliance and adherence capture, safety and AE reporting, and full auditability for regulatory and publication use. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure, so supplement study teams can run compliant trials without enterprise cost.
Supplement studies often have smaller budgets and need flexible build for compliance, safety, and optional ePRO. You need one system that handles consent and data capture without lengthy implementation or per-seat pricing. Enterprise EDC often targets pharma with pricing that doesn’t fit. Capture is built for supplement and nutraceutical studies with controls aligned with 21 CFR Part 11 and pricing that scales with study size.
FAQ
Explore the platform with a free sandbox. No sales call required.
Explore platform